Celgene Corp (NASDAQ:CELG)

95.68
Delayed Data
As of Aug 21
 +0.42 / +0.44%
Today’s Change
58.59
Today|||52-Week Range
98.97
+49.29%
Year-to-Date

Today’s Trading

Previous close95.26
Today’s open95.50
Day’s range95.24 - 95.79
Volume2,087,033
Average volume (3 months)4,639,010
Market cap$67.2B
Data as of 4:15pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)+49.83%
Earnings growth (this year)+22.11%
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+19.26%
P/E ratio13.1
Price/Sales3.08
Price/Book10.77

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.59+1.26%
BMYBristol-Myers Squibb+0.14+0.29%
AGNAllergan+2.14+1.34%
TAKTakeda Pharmaceutica...-0.26-1.55%
Data as of 6:30pm ET, 08/21/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)$2.70
Annual revenue (last year)$15.3B
Annual profit (last year)$4.0B
Net profit margin26.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
CFO, Principal Accounting Officer &
Executive VP
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts